PcComponentes dona más de 26.000 euros a Cruz Roja Juventud esta Navidad para familias vulnerables

PcComponentes dona más de 26.000 euros a Cruz Roja Juventud esta Navidad para familias vulnerables

Mundo: Inside information: Citycon Oyj announces tender offers of outstanding notes due 2024 of Citycon Treasury B.V. and capit

Mundo: Inside information: Citycon Oyj announces tender offers of outstanding notes due 2024 of Citycon Treasury…

Mundo: Inspera announces new Global CEO as company’s international trajectory continues.

Mundo: Inspera announces new Global CEO as company's international trajectory continues.

Mundo: Zentiva amplía su colaboración con Adalvo y refuerza su oferta en Respiratorio, SNC y Dermatología

Mundo: Zentiva amplía su colaboración con Adalvo y refuerza su oferta en Respiratorio, SNC y Dermatología

Mundo: Huma to provide best-in-class digital clinical trials solutions through landmark acquisition of Alcedis

Mundo: Huma to provide best-in-class digital clinical trials solutions through landmark acquisition of Alcedis

Mundo: Valmet to convert two coal-fired boilers to enable biomass combustion for Veolia Group’s subsidiary in Hungary

Mundo: Valmet to convert two coal-fired boilers to enable biomass combustion for Veolia Group's subsidiary in…

Mundo: Storytel streaming revenue in line with forecast for Q4 and full year 2022

Mundo: Storytel streaming revenue in line with forecast for Q4 and full year 2022

Mundo: Orexo initiates exploratory feasibility studies of amorphOX® with two leading biopharmaceutical and vaccine companies

Mundo: Orexo initiates exploratory feasibility studies of amorphOX® with two leading biopharmaceutical and vaccine companies

Mundo: Aker Solutions Wins Rosebank FPSO Contract from Altera Infrastructure

Mundo: Aker Solutions Wins Rosebank FPSO Contract from Altera Infrastructure

Mundo: FDA approves LEQEMBI™ (lecanemab-irmb) under the Accelerated Approval pathway for the treatment of Alzheimer’s disease (

Mundo: FDA approves LEQEMBI™ (lecanemab-irmb) under the Accelerated Approval pathway for the treatment of Alzheimer's disease…